---
schema_version: "secwatch.filing_event.v1"
accession: "0001159036-22-000019"
form_type: "8-K"
ticker: "HALO"
cik: "0001159036"
company_name: "HALOZYME THERAPEUTICS, INC."
filed_at: "2022-03-15T23:59:59+00:00"
generated_at: "2026-06-26T22:38:34.075463+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Moni Miyashita elected to Halozyme Board of Directors

## Summary
- Elected March 11, 2022, term ends at 2023 annual meeting.
- No initial committee assignment on the Board.
- Receives standard non-employee director compensation (cash retainers and restricted stock).
- No arrangements, understandings, or related person transactions with the Company.

## SEC filing metadata
- accession: 0001159036-22-000019
- form_type: 8-K
- ticker: HALO
- cik: 0001159036
- company_name: HALOZYME THERAPEUTICS, INC.
- filed_at: 2022-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1159036/000115903622000019/0001159036-22-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1159036/000115903622000019/halo-20220315.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001159036-22-000019
- JSON: https://secwatch.observer/filing/0001159036-22-000019.json
- Plain text: https://secwatch.observer/filing/0001159036-22-000019.txt

## Key facts
- Executive change
  Moni Miyashita was elected as Director at HALOZYME THERAPEUTICS, INC..
  - Action: elected
  - Role: Director
  source text: On March 11, 2022, Moni Miyashita was elected to the Board of Directors of Halozyme Therapeutics, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1159036/000115903622000019/0001159036-22-000019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.